Bing

Among the companies with shares expected to actively trade in Tuesday’s session are RadioShack Corp. (RSH) Assisted Living Concepts Inc. (ALC ... 7% same-store sales drop shows how last month’s stock surge could show too-early investor …
The Wall Street Journal · ByAnna Prior · 2/26/2013
It wants a leadership shakeup at Vivus ($VVUS)--and it wants it bad ... is the ONLY way for Vivus shareholders to realize value on their investment in the stock," wrote Sam Colin, First Manhattan's senior managing director, in a letter to shareholders ...
FiercePharma · 6/26/2013
Other companies that have spent years developing new medicines—including San Diego-based Arena Pharmaceuticals (NASDAQ: ARNA) and Mountain View, CA-based Vivus (NASDAQ: VVUS) have also seen their applications shot down by the FDA in …
Xconomy · ByLuke Timmerman · 2/1/2011
For earnings, we'll see AOL (AOL), Blue Nile (NILE), JD.com (JD), and WhiteWave Foods (WWAV). Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market ...
Schaeffer's Investment Research · 4/30/2015
As an example, Cooperman noted a stock that he owned, Thomas H ... Jon Najarian is short GLD; Jon Najarian is long VVUS; Jon Najarian is long BTU; Jon Najarian is long FNSR; Jon Najarian is long DFS; Jon Najarian is long OC; Jon Najarian is long S ...
CNBC · ByBruno J. Navarro · 6/19/2013
The biotech industry has continued to thrive in 2014 as the broader markets have struggled to stay in positive territory. The iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB - News) and the SPDR S&P Biotech ETF (NYSEARCA:XBI - News) have …
Finance Yahoo · 3/18/2014
VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets.The company's products …
4 Traders · 8/26/2015
Shares in Arena are not faring very well. The stock is down on the year, but less so than Vivus. Over a three-month period, Arena shares are underperforming Vivus. This makes Arena a more attractive investment. Sales are steady but not explosive ...
Kaptiall WIre · 9/9/2013
Vivus VVUS -9.722222222222221% VIVUS Inc. U.S.: Nasdaq USD 1.3 -0.14-9.722222222222221% /Date(1438722000058-0500)/ Volume (Delayed 15m) : 2233986 AFTER HOURS USD 1.3615 0.0614999999999999 4.730769230769231% Volume (Delayed …
Barron's · 11/20/2013
Arthur Frank, M.D. has been Medical Director of The George Washington University Weight Management Program since 1991. A specialist in internal medicine, Dr. Frank has concentrated his professional activities on the medical management of adult …
Bloomberg · 8/24/2015